Institute of Allergology
Allergies are one of the most common chronic diseases and play a major role in determining the performance of those affected in everyday life, at school, or at work. Allergies are the manifestation of a dysfunction of the body’s immune system and, depending on the type of allergy, they can cause hay fever, reddening of the skin, breathing difficulties, and accompanying symptoms such as insomnia, fatigue, and a significant reduction in performance. It is estimated that 30% of adults will develop at least one allergy during their lifetime.
The Institute of Allergology IFA, founded in 2021, in cooperation with the Fraunhofer Immunology and Allergology IA site, have made it their aim to advance the research and testing of new diagnostic and therapeutic approaches for allergic and other mast cell-activation infectious diseases of the skin. The aim of our work is to continually optimise the treatment options available to our patients to help improve their quality of life, which is sometimes significantly reduced.
To help us achieve this aim, we have more than 250 staff working at seven sites at the Charité Institute of Allergology IFA and Fraunhofer Immunology and Allergology IA:
- Patient Care (outpatient clinic)
- Clinical Trials | Clinical Research
- Basic Sciende | Solution Discovery
- Translational Research | Preclinical Research
- Real World Research